Poster 14: APOLLO: PHASE 3 RANDOMIZED STUDY OF SUBCUTANEOUS DARATUMUMAB
PLUS POMALIDOMIDE AND DEXAMETHASONE (D-PD) VERSUS
POMALIDOMIDE AND DEXAMETHASONE (PD) ALONE IN PATIENTS WITH
RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosanna Delimpasi, Meral
Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila,
Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan
Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M. Schecter, Yanping Qiu, Himal Amin,
Jessica Vermeulen, Robin Carson and Pieter Sonneveld
Poster 15: EFFICACY AND SAFETY PROFILE OF CARFILZOMIB IN RELAPSED REFRACTORY
MULTIPLE MYELOMA (RRMM): ADEQUATE SAFETY PROFILE AND HIGH
EFFICACY IN EARLY TREATMENT LINES
V. Douka, Michail Iskas, Angeliki Giannakopoulou, S. Tagara, Sotiria Dimou-Besikli, C.
Lalayanni, M. Papathanasiou, Chrysanthi Vadikoliou, G. Papaioannou, A. Papalexandri
and Achilles Anagnostopoulos
Poster 16: DURABLE TREATMENT RESPONSE OF RELAPSING CNS PLASMACYTOMA
USING INTRATHECAL CHEMOTHERAPY, RADIOTHERAPY, AND
DARATUMUMAB
Ezzat Elhassadi
Poster 17: THALIDOMIDE AND MULTIPLE MYELOMA LONG TIME SURVIVORS – TWO
CASES REPORT
Sara Ferreira, Cláudia Pedrosa, Margarida Lima, Cristina Gonçalves and Jorge Coutinho
Poster 18: EX VIVO SCREENING OF DRUG SENSITIVITY IDENTIFIES COMBINATIONS THAT
ACT SYNERGISTICALLY AGAINST PATIENT DERIVED MM CELLS
Mariaserena Giliberto, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Sigrid
Skånland, Alexandra Gade, Geir E Tjønnfjord, Fredrik Schjesvold, Ludvig A Munthe2 and
Kjetil Tasken
Poster 19: IMPACT OF PATHOLOGICAL FRACTURES IN MULTIPLE MYELOMA PATIENTS
Susana Gonçalves Pereira, Fátima Costa and Patrícia Ribeiro
Poster 20: PATIENT WITH MULTIPLE MYELOMA AND SEVERE COVID-19 INFECTION
Hina Iqbal and Gregory Monohan
Poster 21: A DECADE OF LIFE WITH DIFFERENT FACES OF THE SAME DISEASE IN A
DEVELOPING COUNTRY
Maduwanthi Jayaweera, M N Dilhani and Senani Williams
Poster 22: ADDITION OF DARATUMUMAB TO MULTIPLE MYELOMA BACKBONE
REGIMENS SIGNIFICANTLY IMPROVE CLINICAL OUTCOMES: A SYSTEMATIC
REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Szabolcs Kiss, Noémi Gede, Péter Hegyi, Bettina Nagy, Rita Deák, Fanni Dembrovszky,
Stefania Bunduc, Tamás Leiner, Bálint Erőss, Zsolt Szakács and Hussain Alizadeh